aluates Reports

$ 0.0

Automative

Global Hepatitis B Vaccines Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Published Date: June 2025

Report Code: QYRE-Auto-30R3489

Global Hepatitis B Vaccines Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027

BUY CHAPTERS

Global Hepatitis B Vaccines Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-30R3489

Report

June 2025

Pages:132

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

GSK

NCPC

Merck

Bio Kangtai

Dynavax

KM Biologics

LG Life Sciences

Serum Institute

AIM Vaccine

Hepatitis B Vaccines Market Size

In 2024, the global market size of Hepatitis B Vaccines was estimated to be worth US$ 1364 million and is forecast to reach approximately US$ 2100 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.

Hepatitis B Vaccines Market

Hepatitis B vaccine is a vaccine that prevents hepatitis B. The first dose is recommended within 24 hours of birth with either two or three more doses given after that. This includes those with poor immune function such as from HIV/AIDS and those born premature. It is also recommended that health-care workers be vaccinated. In healthy people routine immunization results in more than 95% of people being protected.

Global key players of Hepatitis B Vaccines include GSK, Dynavax, NCPC, etc. The top three players hold a share about 64%. North America is the largest market for Hepatitis B Vaccines, which has a share about 45%, followed by Asia-Pacific and Europe with share 31% and 17%, separately. In terms of product type, Yeast Derived is the largest segment, occupied for a share of 85%. In terms of application, Adult is the largest field with a share about 64%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Hepatitis B Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis B Vaccines.

The Hepatitis B Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hepatitis B Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Hepatitis B Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Hepatitis B Vaccines Market Report

Report Metric	Details
Report Name	Hepatitis B Vaccines Market
Forecasted market size in 2031	approximately US$ 2100 million
CAGR	6.5%
Forecasted years	2025 - 2031
Segment by Type	Yeast Derived CHO Derived
Segment by Application	Children Adult
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GSK, NCPC, Merck, Bio Kangtai, Dynavax, AIM Vaccine, KM Biologics, LG Life Sciences, Serum Institute
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Hepatitis B Vaccines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Hepatitis B Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hepatitis B Vaccines sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the Hepatitis B Vaccines Market size in 2031?

Ans: The Hepatitis B Vaccines Market size in 2031 will be approximately US$ 2100 million.

What is the market share of major companies in Hepatitis B Vaccines Market?

Ans: The top three players hold a share about 64%.

What is the Hepatitis B Vaccines Market share by region?

Ans: North America is the largest market for Hepatitis B Vaccines, which has a share about 45%, followed by Asia-Pacific and Europe with share 31% and 17%, separately.

What is the Hepatitis B Vaccines Market share by type?

Ans: In terms of product type, Yeast Derived is the largest segment, occupied for a share of 85%.

What is the Hepatitis B Vaccines Market share by application?

Ans: In terms of application, Adult is the largest field with a share about 64%.

Who are the main players in the Hepatitis B Vaccines Market report?

Ans: The main players in the Hepatitis B Vaccines Market are GSK, NCPC, Merck, Bio Kangtai, Dynavax, AIM Vaccine, KM Biologics, LG Life Sciences, Serum Institute

What are the Application segmentation covered in the Hepatitis B Vaccines Market report?

Ans: The Applications covered in the Hepatitis B Vaccines Market report are Children, Adult

What are the Type segmentation covered in the Hepatitis B Vaccines Market report?

Ans: The Types covered in the Hepatitis B Vaccines Market report are Yeast Derived, CHO Derived

1 Study Coverage

1.1 Hepatitis B Vaccines Product Introduction

1.2 Market by Type

1.2.1 Global Hepatitis B Vaccines Market Size Growth Rate by Type (2020 VS 2024 VS 2031)

1.2.2 Yeast Derived

1.2.3 CHO Derived

1.3 Market by Application

1.3.1 Global Hepatitis B Vaccines Market Size Growth Rate by Application (2020 VS 2024 VS 2031)

1.3.2 Children

1.3.3 Adult

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Hepatitis B Vaccines Market Size Estimates and Forecasts

2.1.1 Global Hepatitis B Vaccines Revenue 2020-2031

2.1.2 Global Hepatitis B Vaccines Sales 2020-2031

2.2 Hepatitis B Vaccines Market Size by Region: 2024 Versus 2031

2.3 Hepatitis B Vaccines Sales by Region (2020-2031)

2.3.1 Global Hepatitis B Vaccines Sales by Region: 2020-2025

2.3.2 Global Hepatitis B Vaccines Sales Forecast by Region (2026-2031)

2.3.3 Global Hepatitis B Vaccines Sales Market Share by Region (2020-2031)

2.4 Hepatitis B Vaccines Market Estimates and Projections by Region (2026-2031)

2.4.1 Global Hepatitis B Vaccines Revenue by Region: 2020-2025

2.4.2 Global Hepatitis B Vaccines Revenue Forecast by Region (2026-2031)

2.4.3 Global Hepatitis B Vaccines Revenue Market Share by Region (2020-2031)

3 Market Segments

3.1 Breakdown Data by Type

3.1.1 Global Hepatitis B Vaccines Sales by Type (2020-2031)

3.1.1.1 Global Hepatitis B Vaccines Sales Volume by Type (2020-2031)

3.1.1.2 Global Hepatitis B Vaccines Sales Market Share by Type (2020-2031)

3.1.2 Global Hepatitis B Vaccines Revenue by Type (2020-2031)

3.1.2.1 Global Hepatitis B Vaccines Revenue by Type (2020-2031)

3.1.2.2 Global Hepatitis B Vaccines Revenue Market Share by Type (2020-2031)

3.1.3 Hepatitis B Vaccines Average Selling Price (ASP) by Type (2020-2031)

3.2 Breakdown Data by Application

3.2.1 Global Hepatitis B Vaccines Sales by Application (2020-2031)

3.2.1.1 Global Hepatitis B Vaccines Sales Volume by Application (2020-2031)

3.2.1.2 Global Hepatitis B Vaccines Sales Market Share by Application (2020-2031)

3.2.2 Global Hepatitis B Vaccines Revenue by Application (2020-2031)

3.2.2.1 Global Hepatitis B Vaccines Revenue by Application (2020-2031)

3.2.2.2 Global Hepatitis B Vaccines Revenue Market Share by Application (2020-2031)

3.2.3 Hepatitis B Vaccines Average Selling Price (ASP) by Application (2020-2031)

3.3 by Type and by Application Crossing Analysis

3.3.1 Yeast Derived of Hepatitis B Vaccines Revenue Market Share by Application

3.3.2 CHO Derived of Hepatitis B Vaccines Revenue Market Share by Application

4 Global Hepatitis B Vaccines by Manufacturers

4.1 Global Top Hepatitis B Vaccines Manufacturers by Sales (2020-2025)

4.1.1 Global Hepatitis B Vaccines Sales by Manufacturer (2020-2025)

4.1.2 Global Hepatitis B Vaccines Sales Market Share by Manufacturer (2020-2025)

4.2 Global Top Hepatitis B Vaccines Manufacturers by Revenue (2020-2025)

4.2.1 Global Hepatitis B Vaccines Revenue by Manufacturer (2020-2025)

4.2.2 Global Hepatitis B Vaccines Revenue Share by Manufacturer (2020-2025)

4.3 Global Hepatitis B Vaccines Price by Manufacturer (2020-2025)

4.4 Competitive Landscape

4.4.1 Key Hepatitis B Vaccines Manufacturers Covered: Ranking by Revenue

4.4.2 Global Hepatitis B Vaccines Market Concentration Ratio (CR5 and HHI) & (2020-2025)

4.4.3 Global Hepatitis B Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.5 Global Hepatitis B Vaccines Manufacturing Base Distribution, Product Type

4.5.1 Hepatitis B Vaccines Manufacturers Manufacturing Base Distribution, Headquarters

4.5.2 Date of International Manufacturers Enter into Hepatitis B Vaccines Market

4.5.3 Manufacturers Hepatitis B Vaccines Product Type and Application

4.5.4 Yeast Derived Market Sales of Hepatitis B Vaccines by Manufacturer

4.5.5 CHO Derived Market Sales of Hepatitis B Vaccines by Manufacturer

4.6 Manufacturers Mergers & Acquisitions, Expansion Plans

5 Company Profiles

5.1 GSK

5.1.1 GSK Company Information

5.1.2 GSK Description, Business Overview

5.1.3 GSK Hepatitis B Vaccines Products Offered

5.1.4 GSK Hepatitis B Vaccines Sales, Revenue and Gross Margin (2020-2025)

5.1.5 GSK Hepatitis B Vaccines Sales by Product in 2024

5.1.6 GSK Hepatitis B Vaccines Sales by Application in 2024

5.1.7 GSK Hepatitis B Vaccines Sales by Geographic Area in 2024

5.1.8 GSK Recent Developments

5.2 NCPC

5.2.1 NCPC Company Information

5.2.2 NCPC Description, Business Overview

5.2.3 NCPC Hepatitis B Vaccines Products Offered

5.2.4 NCPC Hepatitis B Vaccines Sales, Revenue and Gross Margin (2020-2025)

5.2.5 NCPC Hepatitis B Vaccines Sales by Product in 2024

5.2.6 NCPC Hepatitis B Vaccines Sales by Application in 2024

5.2.7 NCPC Hepatitis B Vaccines Sales by Geographic Area in 2024

5.2.8 NCPC Recent Developments

5.3 Merck

5.3.1 Merck Company Information

5.3.2 Merck Description, Business Overview

5.3.3 Merck Hepatitis B Vaccines Products Offered

5.3.4 Merck Hepatitis B Vaccines Sales, Revenue and Gross Margin (2020-2025)

5.3.5 Merck Hepatitis B Vaccines Sales by Product in 2024

5.3.6 Merck Hepatitis B Vaccines Sales by Application in 2024

5.3.7 Merck Hepatitis B Vaccines Sales by Geographic Area in 2024

5.3.8 Merck Recent Developments

5.4 Bio Kangtai

5.4.1 Bio Kangtai Company Information

5.4.2 Bio Kangtai Description, Business Overview

5.4.3 Bio Kangtai Hepatitis B Vaccines Products Offered

5.4.4 Bio Kangtai Hepatitis B Vaccines Sales, Revenue and Gross Margin (2020-2025)

5.4.5 Bio Kangtai Hepatitis B Vaccines Sales by Product in 2024

5.4.6 Bio Kangtai Hepatitis B Vaccines Sales by Application in 2024

5.4.7 Bio Kangtai Hepatitis B Vaccines Sales by Geographic Area in 2024

5.4.8 Bio Kangtai Recent Developments

5.5 Dynavax

5.5.1 Dynavax Company Information

5.5.2 Dynavax Description, Business Overview

5.5.3 Dynavax Hepatitis B Vaccines Products Offered

5.5.4 Dynavax Hepatitis B Vaccines Sales, Revenue and Gross Margin (2020-2025)

5.5.5 Dynavax Hepatitis B Vaccines Sales by Product in 2024

5.5.6 Dynavax Hepatitis B Vaccines Sales by Application in 2024

5.5.7 Dynavax Hepatitis B Vaccines Sales by Geographic Area in 2024

5.5.8 Dynavax Recent Developments

5.6 AIM Vaccine

5.6.1 AIM Vaccine Company Information

5.6.2 AIM Vaccine Description, Business Overview

5.6.3 AIM Vaccine Hepatitis B Vaccines Products Offered

5.6.4 AIM Vaccine Hepatitis B Vaccines Sales, Revenue and Gross Margin (2020-2025)

5.6.5 AIM Vaccine Hepatitis B Vaccines Sales by Product in 2024

5.6.6 AIM Vaccine Hepatitis B Vaccines Sales by Application in 2024

5.6.7 AIM Vaccine Hepatitis B Vaccines Sales by Geographic Area in 2024

5.6.8 AIM Vaccine Recent Developments

5.7 KM Biologics

5.7.1 KM Biologics Company Information

5.7.2 KM Biologics Description, Business Overview

5.7.3 KM Biologics Hepatitis B Vaccines Products Offered

5.7.4 KM Biologics Hepatitis B Vaccines Sales, Revenue and Gross Margin (2020-2025)

5.7.5 KM Biologics Hepatitis B Vaccines Sales by Product in 2024

5.7.6 KM Biologics Hepatitis B Vaccines Sales by Application in 2024

5.7.7 KM Biologics Hepatitis B Vaccines Sales by Geographic Area in 2024

5.7.8 KM Biologics Recent Developments

5.8 LG Life Sciences

5.8.1 LG Life Sciences Company Information

5.8.2 LG Life Sciences Description, Business Overview

5.8.3 LG Life Sciences Hepatitis B Vaccines Products Offered

5.8.4 LG Life Sciences Hepatitis B Vaccines Sales, Revenue and Gross Margin (2020-2025)

5.8.5 LG Life Sciences Hepatitis B Vaccines Sales by Product in 2024

5.8.6 LG Life Sciences Hepatitis B Vaccines Sales by Application in 2024

5.8.7 LG Life Sciences Hepatitis B Vaccines Sales by Geographic Area in 2024

5.8.8 LG Life Sciences Recent Developments

5.9 Serum Institute

5.9.1 Serum Institute Company Information

5.9.2 Serum Institute Description, Business Overview

5.9.3 Serum Institute Hepatitis B Vaccines Products Offered

5.9.4 Serum Institute Hepatitis B Vaccines Sales, Revenue and Gross Margin (2020-2025)

5.9.5 Serum Institute Hepatitis B Vaccines Sales by Product in 2024

5.9.6 Serum Institute Hepatitis B Vaccines Sales by Application in 2024

5.9.7 Serum Institute Hepatitis B Vaccines Sales by Geographic Area in 2024

5.9.8 Serum Institute Recent Developments

6 North America

6.1 North America Hepatitis B Vaccines Market Size YoY Growth 2020-2031

6.2 North America Hepatitis B Vaccines Market Facts & Figures by Country

6.2.1 North America Hepatitis B Vaccines Sales by Country (2020-2031)

6.2.2 North America Hepatitis B Vaccines Revenue by Country (2020-2031)

6.3 North America Hepatitis B Vaccines Sales by Type (2020-2025)

6.4 North America Hepatitis B Vaccines Sales by Application (2020-2025)

7 Asia-Pacific

7.1 Asia-Pacific Hepatitis B Vaccines Market Size YoY Growth 2020-2031

7.2 Asia-Pacific Hepatitis B Vaccines Market Facts & Figures by Region

7.2.1 Asia-Pacific Hepatitis B Vaccines Sales by Region (2020-2031)

7.2.2 Asia-Pacific Hepatitis B Vaccines Revenue by Region (2020-2031)

7.3 Asia-Pacific Hepatitis B Vaccines Sales by Type (2020-2025)

7.4 Asia-Pacific Hepatitis B Vaccines Sales by Application (2020-2025)

8 Europe

8.1 Europe Hepatitis B Vaccines Market Size YoY Growth 2020-2031

8.2 Europe Hepatitis B Vaccines Market Facts & Figures by Country

8.2.1 Europe Hepatitis B Vaccines Sales by Country (2020-2031)

8.2.2 Europe Hepatitis B Vaccines Revenue by Country (2020-2031)

8.3 Europe Hepatitis B Vaccines Sales by Type (2020-2025)

8.4 Europe Hepatitis B Vaccines Sales by Application (2020-2025)

9 Latin America

9.1 Latin America Hepatitis B Vaccines Market Size YoY Growth 2020-2031

9.2 Latin America Hepatitis B Vaccines Market Facts & Figures by Country

9.2.1 Latin America Hepatitis B Vaccines Sales by Country (2020-2031)

9.2.2 Latin America Hepatitis B Vaccines Revenue by Country (2020-2031)

9.3 Latin America Hepatitis B Vaccines Sales by Type (2020-2025)

9.4 Latin America Hepatitis B Vaccines Sales by Application (2020-2025)

10 Middle East and Africa

10.1 Latin America Hepatitis B Vaccines Market Size YoY Growth 2020-2031

10.2 Middle East and Africa Hepatitis B Vaccines Market Facts & Figures by Country

10.2.1 Middle East and Africa Hepatitis B Vaccines Sales by Country (2020-2031)

10.2.2 Middle East and Africa Hepatitis B Vaccines Revenue by Country (2020-2031)

10.3 Middle East and Africa Hepatitis B Vaccines Sales by Type (2020-2025)

10.4 Middle East and Africa Hepatitis B Vaccines Sales by Application (2020-2025)

11 Supply Chain and Sales Channel analysis

11.1 Hepatitis B Vaccines Supply Chain Analysis

11.2 Hepatitis B Vaccines Key Raw Materials and Upstream Suppliers

11.3 Hepatitis B Vaccines Clients Analysis

11.4 Hepatitis B Vaccines Sales Channel and Sales Model Analysis

11.4.1 Hepatitis B Vaccines Distribution Channel Analysis: Indirect Sales VS Direct Sales

11.4.2 Hepatitis B Vaccines Distribution Channel Analysis: Online Sales VS Offline Sales

11.4.3 Hepatitis B Vaccines Distributors

12 Hepatitis B Vaccines Market Dynamics

12.1 Hepatitis B Vaccines Industry Trends

12.2 Hepatitis B Vaccines Market Drivers

12.3 Hepatitis B Vaccines Market Challenges

12.4 Hepatitis B Vaccines Market Restraints

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.1.1 Research Programs/Design

14.1.1.2 Market Size Estimation

14.1.1.3 Market Breakdown and Data Triangulation

14.1.2 Data Source

14.1.2.1 Secondary Sources

14.1.2.2 Primary Sources

14.2 Author Details

14.3 Disclaimer

FEATURED COMPANIES

GSK

NCPC

Merck

Bio Kangtai

Dynavax

KM Biologics

LG Life Sciences

Serum Institute

AIM Vaccine

List of Tables

Table 1. Global Hepatitis B Vaccines Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Hepatitis B Vaccines Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Hepatitis B Vaccines Market Size by Region (US$ Million): 2024 VS 2031

Table 4. Global Hepatitis B Vaccines Sales by Region (2020-2025) & (M Doses)

Table 5. Global Hepatitis B Vaccines Sales Forecast by Region (2026-2031) & (M Doses)

Table 6. Global Hepatitis B Vaccines Revenue by Region (2020-2025) & (US$ Million)

Table 7. Global Hepatitis B Vaccines Revenue Forecast by Region (2026-2031) & (US$ Million)

Table 8. Global Hepatitis B Vaccines Sales Volume by Type (2020-2025) & (M Doses)

Table 9. Global Hepatitis B Vaccines Sales Volume by Type (2026-2031) & (M Doses)

Table 10. Global Hepatitis B Vaccines Revenue by Type (2020-2025) & (US$ Million)

Table 11. Global Hepatitis B Vaccines Revenue Forecast by Type (2026-2031) & (US$ Million)

Table 12. Global Hepatitis B Vaccines Sales Volume by Application (2020-2025) & (M Doses)

Table 13. Global Hepatitis B Vaccines Sales Volume by Application (2026-2031) & (M Doses)

Table 14. Global Hepatitis B Vaccines Revenue by Application (2020-2025) & (US$ Million)

Table 15. Global Hepatitis B Vaccines Revenue by Application (2026-2031) & (US$ Million)

Table 16. Global Hepatitis B Vaccines Sales by Manufacturer (2020-2025) & (M Doses)

Table 17. Global Hepatitis B Vaccines Sales Share by Manufacturer (2020-2025)

Table 18. Hepatitis B Vaccines Revenue by Manufacturer (2020-2025) & (US$ Million)

Table 19. Hepatitis B Vaccines Revenue Share by Manufacturer (2020-2025)

Table 20. Key Manufacturers Hepatitis B Vaccines Price (2020-2025) & (US$/Dose)

Table 21. Ranking of Global Top Hepatitis B Vaccines Manufacturers by Revenue (US$ Million) in 2024

Table 22. Global Hepatitis B Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)

Table 23. Global Hepatitis B Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis B Vaccines as of 2024)

Table 24. Hepatitis B Vaccines Manufacturers Manufacturing Base Distribution and Headquarters

Table 25. Date of International Manufacturers Enter into Hepatitis B Vaccines Market

Table 26. Manufacturers Hepatitis B Vaccines Product Type and Application

Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 28. GSK Company Information

Table 29. GSK Description and Business Overview

Table 30. GSK Hepatitis B Vaccines Product

Table 31. GSK Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 32. GSK Sales Proportion of Hepatitis B Vaccines by Product in 2024

Table 33. GSK Sales Proportion of Hepatitis B Vaccines by Application in 2024

Table 34. GSK Sales Proportion of Hepatitis B Vaccines by Geographic Area in 2024

Table 35. GSK Recent Developments

Table 36. NCPC Company Information

Table 37. NCPC Description and Business Overview

Table 38. NCPC Hepatitis B Vaccines Product

Table 39. NCPC Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 40. NCPC Sales Proportion of Hepatitis B Vaccines by Product in 2024

Table 41. NCPC Sales Proportion of Hepatitis B Vaccines by Application in 2024

Table 42. NCPC Sales Proportion of Hepatitis B Vaccines by Geographic Area in 2024

Table 43. NCPC Recent Developments

Table 44. Merck Company Information

Table 45. Merck Description and Business Overview

Table 46. Merck Hepatitis B Vaccines Product

Table 47. Merck Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 48. Merck Sales Proportion of Hepatitis B Vaccines by Product in 2024

Table 49. Merck Sales Proportion of Hepatitis B Vaccines by Application in 2024

Table 50. Merck Sales Proportion of Hepatitis B Vaccines by Geographic Area in 2024

Table 51. Merck Recent Developments

Table 52. Bio Kangtai Company Information

Table 53. Bio Kangtai Description and Business Overview

Table 54. Bio Kangtai Hepatitis B Vaccines Product

Table 55. Bio Kangtai Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 56. Bio Kangtai Sales Proportion of Hepatitis B Vaccines by Product in 2024

Table 57. Bio Kangtai Sales Proportion of Hepatitis B Vaccines by Application in 2024

Table 58. Bio Kangtai Sales Proportion of Hepatitis B Vaccines by Geographic Area in 2024

Table 59. Bio Kangtai Recent Developments

Table 60. Dynavax Company Information

Table 61. Dynavax Description and Business Overview

Table 62. Dynavax Hepatitis B Vaccines Product

Table 63. Dynavax Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 64. Dynavax Sales Proportion of Hepatitis B Vaccines by Product in 2024

Table 65. Dynavax Sales Proportion of Hepatitis B Vaccines by Application in 2024

Table 66. Dynavax Sales Proportion of Hepatitis B Vaccines by Geographic Area in 2024

Table 67. Dynavax Recent Developments

Table 68. AIM Vaccine Company Information

Table 69. AIM Vaccine Description and Business Overview

Table 70. AIM Vaccine Hepatitis B Vaccines Product

Table 71. AIM Vaccine Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 72. AIM Vaccine Sales Proportion of Hepatitis B Vaccines by Product in 2024

Table 73. AIM Vaccine Sales Proportion of Hepatitis B Vaccines by Application in 2024

Table 74. AIM Vaccine Sales Proportion of Hepatitis B Vaccines by Geographic Area in 2024

Table 75. AIM Vaccine Recent Developments

Table 76. KM Biologics Company Information

Table 77. KM Biologics Description and Business Overview

Table 78. KM Biologics Hepatitis B Vaccines Product

Table 79. KM Biologics Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 80. KM Biologics Sales Proportion of Hepatitis B Vaccines by Product in 2024

Table 81. KM Biologics Sales Proportion of Hepatitis B Vaccines by Application in 2024

Table 82. KM Biologics Sales Proportion of Hepatitis B Vaccines by Geographic Area in 2024

Table 83. KM Biologics Recent Developments

Table 84. LG Life Sciences Company Information

Table 85. LG Life Sciences Description and Business Overview

Table 86. LG Life Sciences Hepatitis B Vaccines Product

Table 87. LG Life Sciences Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 88. LG Life Sciences Sales Proportion of Hepatitis B Vaccines by Product in 2024

Table 89. LG Life Sciences Sales Proportion of Hepatitis B Vaccines by Application in 2024

Table 90. LG Life Sciences Sales Proportion of Hepatitis B Vaccines by Geographic Area in 2024

Table 91. LG Life Sciences Recent Developments

Table 92. Serum Institute Company Information

Table 93. Serum Institute Description and Business Overview

Table 94. Serum Institute Hepatitis B Vaccines Product

Table 95. Serum Institute Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 96. Serum Institute Sales Proportion of Hepatitis B Vaccines by Product in 2024

Table 97. Serum Institute Sales Proportion of Hepatitis B Vaccines by Application in 2024

Table 98. Serum Institute Sales Proportion of Hepatitis B Vaccines by Geographic Area in 2024

Table 99. Serum Institute Recent Developments

Table 100. North America Hepatitis B Vaccines Sales by Country (2020-2025) & (M Doses)

Table 101. North America Hepatitis B Vaccines Sales by Country (2026-2031) & (M Doses)

Table 102. North America Hepatitis B Vaccines Revenue by Country (2020-2025) & (US$ Million)

Table 103. North America Hepatitis B Vaccines Revenue by Country (2026-2031) & (US$ Million)

Table 104. North America Hepatitis B Vaccines Sales by Type (2020-2025) & (M Doses)

Table 105. North America Hepatitis B Vaccines Sales by Application (2020-2025) & (M Doses)

Table 106. Asia-Pacific Hepatitis B Vaccines Sales by Region (2020-2025) & (M Doses)

Table 107. Asia-Pacific Hepatitis B Vaccines Sales by Region (2026-2031) & (M Doses)

Table 108. Asia-Pacific Hepatitis B Vaccines Revenue by Region (2020-2025) & (US$ Million)

Table 109. Asia-Pacific Hepatitis B Vaccines Revenue by Region (2026-2031) & (US$ Million)

Table 110. Asia-Pacific Hepatitis B Vaccines Sales by Type (2020-2025) & (M Doses)

Table 111. Asia-Pacific Hepatitis B Vaccines Sales by Application (2020-2025) & (M Doses)

Table 112. Europe Hepatitis B Vaccines Sales by Country (2020-2025) & (M Doses)

Table 113. Europe Hepatitis B Vaccines Sales by Country (2026-2031) & (M Doses)

Table 114. Europe Hepatitis B Vaccines Revenue by Country (2020-2025) & (US$ Million)

Table 115. Europe Hepatitis B Vaccines Revenue by Country (2026-2031) & (US$ Million)

Table 116. Europe Hepatitis B Vaccines Sales by Type (2020-2025) & (M Doses)

Table 117. Europe Hepatitis B Vaccines Sales by Application (2020-2025) & (M Doses)

Table 118. Latin America Hepatitis B Vaccines Sales by Country (2020-2025) & (M Doses)

Table 119. Latin America Hepatitis B Vaccines Sales by Country (2026-2031) & (M Doses)

Table 120. Latin America Hepatitis B Vaccines Revenue by Country (2020-2025) & (US$ Million)

Table 121. Latin America Hepatitis B Vaccines Revenue by Country (2026-2031) & (US$ Million)

Table 122. Latin America Hepatitis B Vaccines Sales by Type (2020-2025) & (M Doses)

Table 123. Latin America Hepatitis B Vaccines Sales by Application (2020-2025) & (M Doses)

Table 124. Middle East and Africa Hepatitis B Vaccines Sales by Country (2020-2025) & (M Doses)

Table 125. Middle East and Africa Hepatitis B Vaccines Sales by Country (2026-2031) & (M Doses)

Table 126. Middle East and Africa Hepatitis B Vaccines Revenue by Country (2020-2025) & (US$ Million)

Table 127. Middle East and Africa Hepatitis B Vaccines Revenue by Country (2026-2031) & (US$ Million)

Table 128. Middle East and Africa Hepatitis B Vaccines Sales by Type (2020-2025) & (M Doses)

Table 129. Middle East and Africa Hepatitis B Vaccines Sales by Application (2020-2025) & (M Doses)

Table 130. Hepatitis B Vaccines Key Raw Materials, Industry Status and Trend

Table 131. Hepatitis B Vaccines Key Raw Materials and Upstream Suppliers

Table 132. Hepatitis B Vaccines Clients Status and Trend

Table 133. Hepatitis B Vaccines Typical Clients

Table 134. Hepatitis B Vaccines Distributors

Table 135. Hepatitis B Vaccines Market Trends

Table 136. Hepatitis B Vaccines Market Drivers

Table 137. Hepatitis B Vaccines Market Challenges

Table 138. Hepatitis B Vaccines Market Restraints

Table 139. Research Programs/Design for This Report

Table 140. Key Data Information from Secondary Sources

Table 141. Key Data Information from Primary Sources

Table 142. QYR Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Hepatitis B Vaccines Product Picture

Figure 2. Global Hepatitis B Vaccines Market Size by Type (US$ Million): 2020 VS 2024 VS 2031

Figure 3. Global Hepatitis B Vaccines Sales Market Share by Type in 2024 & 2031

Figure 4. Yeast Derived Product Picture

Figure 5. CHO Derived Product Picture

Figure 6. Global Hepatitis B Vaccines Market Size by Application (US$ Million): 2020 VS 2024 VS 2031

Figure 7. Global Hepatitis B Vaccines Sales Market Share by Application in 2024 & 2031

Figure 8. Children

Figure 9. Adult

Figure 10. Hepatitis B Vaccines Report Years Considered

Figure 11. Global Hepatitis B Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Hepatitis B Vaccines Market Size 2020-2031 (US$ Million)

Figure 13. Global Hepatitis B Vaccines Sales 2020-2031 (M Doses)

Figure 14. Global Hepatitis B Vaccines Sales Market Share Forecast by Region (2020-2031)

Figure 15. Global Hepatitis B Vaccines Revenue Market Share by Region (2020-2031)

Figure 16. Global Hepatitis B Vaccines Sales Market Share Forecast by Type (2020-2031)

Figure 17. Global Hepatitis B Vaccines Revenue Market Share Forecast by Type (2020-2031)

Figure 18. Hepatitis B Vaccines Average Selling Price (ASP) by Type (2020-2025) & (US$/Dose)

Figure 19. Global Hepatitis B Vaccines Sales Market Share Forecast by Application (2020-2031)

Figure 20. Global Hepatitis B Vaccines Revenue Market Share Forecast by Application (2020-2031)

Figure 21. Hepatitis B Vaccines Average Selling Price (ASP) by Application (2020-2025) & (US$/Dose)

Figure 22. Yeast Derived of Hepatitis B Vaccines Revenue Market Share by Application, 2024 VS 2031

Figure 23. CHO Derived of Hepatitis B Vaccines Revenue Market Share by Application, 2024 VS 2031

Figure 24. Global Hepatitis B Vaccines Sales Share by Manufacturer in 2024

Figure 25. Hepatitis B Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 26. Yeast Derived Market Sales Proportion by Manufacturer in 2024

Figure 27. CHO Derived Market Sales Proportion by Manufacturer in 2024

Figure 28. North America Hepatitis B Vaccines Revenue 2020-2031 (US$ Million)

Figure 29. North America Hepatitis B Vaccines Sales Market Share by Type (2020-2025)

Figure 30. North America Hepatitis B Vaccines Sales Market Share by Application (2020-2025)

Figure 31. Asia-Pacific Hepatitis B Vaccines Revenue 2020-2031 (US$ Million)

Figure 32. Asia-Pacific Hepatitis B Vaccines Sales Market Share by Region (2020-2031)

Figure 33. Asia-Pacific Hepatitis B Vaccines Revenue Market Share by Region (2020-2031)

Figure 34. Asia-Pacific Hepatitis B Vaccines Sales Market Share by Type (2020-2025)

Figure 35. Asia-Pacific Hepatitis B Vaccines Sales Market Share by Application (2020-2025)

Figure 36. Europe Hepatitis B Vaccines Revenue Growth Rate 2020-2031 (US$ Million)

Figure 37. Europe Hepatitis B Vaccines Sales Market Share by Country (2020-2031)

Figure 38. Europe Hepatitis B Vaccines Revenue Market Share by Country (2020-2031)

Figure 39. Europe Hepatitis B Vaccines Sales Market Share by Type (2020-2025)

Figure 40. Europe Hepatitis B Vaccines Sales Market Share by Application (2020-2025)

Figure 41. Latin America Hepatitis B Vaccines Revenue Growth Rate 2020-2031 (US$ Million)

Figure 42. Latin America Hepatitis B Vaccines Sales Market Share by Country (2020-2031)

Figure 43. Latin America Hepatitis B Vaccines Revenue Market Share by Country (2020-2025)

Figure 44. Latin America Hepatitis B Vaccines Sales Market Share by Type (2020-2025)

Figure 45. Latin America Hepatitis B Vaccines Sales Market Share by Application (2020-2025)

Figure 46. Middle East and Africa Hepatitis B Vaccines Revenue Growth Rate 2020-2031 (US$ Million)

Figure 47. Middle East and Africa Hepatitis B Vaccines Sales Market Share by Country (2020-2031)

Figure 48. Middle East and Africa Hepatitis B Vaccines Revenue Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Hepatitis B Vaccines Sales Market Share by Type (2020-2025)

Figure 50. Middle East and Africa Hepatitis B Vaccines Sales Market Share by Application (2020-2025)

Figure 51. Hepatitis B Vaccines Supply Chain (Upstream and Downstream Market)

Figure 52. Global Production Market Share of Hepatitis B Vaccines Raw Materials by Region in 2024

Figure 53. Hepatitis B Vaccines Distribution Channels

Figure 54. Global Hepatitis B Vaccines Percentage 2020-2031: Indirect Sales VS Direct Sales

Figure 55. Global Hepatitis B Vaccines Percentage 2020-2031: Online Sales VS Offline Sales

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$5900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Mono Hepatitis B Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Hepatitis B Vaccine Recombinant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Recombinant Hepatitis B Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hepatitis A and B Vaccine Market Research Report 2025

Global Hepatitis A and B Vaccination Market Research Report 2025

Hepatitis A and B Combined Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Hepatitis Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hepatitis A Vaccination Market Research Report 2025

Mono Hepatitis Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Mono Hepatitis A Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Hepatitis A Vaccine Market

Global Inactivated Hepatitis A Vaccine Market Research Report 2024

Global Hepatitis B Human Immunoglobulin Market Research Report 2024

Hepatitis B Infectious Disease Tests Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hepatitis B Immune Globulin Market Research Report 2025

Global Hepatitis B Treatment Market Insights Forecast to 2030

Global Human Hepatitis B Immunoglobulin for Intravenous Injection Market Research Report 2024

Hepatitis B Test Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Hepatitis B Virus Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions